New Republic Capital’s Eli Lilly LLY Stock Holding History

New Republic Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.51M	Sell	1,643 -1,101	-40%	-$1.12M	0.51%	39
2025 Q4	$2.95M	Buy	2,744 +1,411	+106%	+$1.35M	0.79%	26
2025 Q3	$1.02M	Buy	1,333 +37	+3%	+$27.5K	0.31%	42
2025 Q2	$1.01M	Buy	1,296 +61	+5%	+$47.4K	0.36%	40
2025 Q1	$1.02M	Sell	1,235 -13	-1%	-$10.8K	0.44%	35
2024 Q4	$964K	Buy	1,248 +68	+6%	+$56.3K	0.63%	33
2024 Q3	$1.05M	Buy	1,180 +16	+1%	+$14.4K	0.6%	37
2024 Q2	$1.05M	Buy	1,164 +31	+3%	+$24.8K	0.53%	37
2024 Q1	$881K	Buy	1,133 +51	+5%	+$36.3K	0.56%	40
2023 Q4	$631K	Buy	1,082 +145	+15%	+$84.6K	0.45%	48
2023 Q3	$503K	Buy	937 +40	+4%	+$20.6K	0.41%	58
2023 Q2	$421K	Buy	897 +54	+6%	+$22.6K	0.29%	66
2023 Q1	$289K	Buy	843 +156	+23%	+$52.6K	0.22%	90
2022 Q4	$251K	Buy	+687	New	+$244K	0.2%	87

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

New Republic Capital's LLY Position: Q1 2026 in Review

New Republic Capital reduced its Eli Lilly (LLY) stake by 40% in Q1 2026, selling an estimated $1.12M and leaving 1,643 shares worth $1.51M. The position accounts for 0.51% of the portfolio, ranked #39.

New Republic Capital first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.95M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

New Republic Capital held 1,643 shares of Eli Lilly worth $1.51M as of Q1 2026.
New Republic Capital sold 1,101 Eli Lilly shares in Q1 2026, an estimated $1.12M.
Eli Lilly made up 0.51% of New Republic Capital's portfolio in Q1 2026, its #39 holding.
New Republic Capital first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
New Republic Capital's Eli Lilly position peaked at $2.95M in Q4 2025.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on New Republic Capital's 13F filing for Q1 2026, filed 1 May 2026.